TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34058610

Group type: EXPERIMENTAL
Intervention: ImproveYourMood (monitoring and content; n = 62)
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: ImproveYourMood+ (monitoring, content, and prompts; n = 60)
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: MoodTracker (monitoring-only; n = 58)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Waitlist control group (n = 55)
Number of subjects: 235
Study: 32091610

Group type: EXPERIMENTAL
Intervention: Digital Cognitive Aid (MAX) used in scenarios (MAX+)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Memory and training alone (MAX‐)
Number of subjects: 0
Study: 35210153

Group type: EXPERIMENTAL
Intervention: First stage of a planned 2-stage exchange
Number of subjects: 66

Group type: COMPARATOR
Intervention: 1-stage exchange
Number of subjects: 66
Study: 33161336

Group type: EXPERIMENTAL
Intervention: Accelerated partial breast irradiation (APBI) using 3D-CRT and IG-IMRT
Number of subjects: 104
Study: 33918616

Group type: EXPERIMENTAL
Intervention: Aerobic continuous and interval training under hypoxia
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normoxic training
Number of subjects: 20
Study: 32143649

Group type: EXPERIMENTAL
Intervention: Words format
Number of subjects: 234

Group type: COMPARATOR
Intervention: Control (standard lab report)
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Graph format
Number of subjects: 234
Study: 36370185

Group type: EXPERIMENTAL
Intervention: Prolonged prophylactic antibiotic therapy (PAT) group (Group B)
Number of subjects: 120

Group type: COMPARATOR
Intervention: No prolonged prophylactic antibiotic therapy group (Group A)
Number of subjects: 120
Study: 33307682

Group type: EXPERIMENTAL
Intervention: GLP-1-CYA (a GLP-1 analogue with cysteic acid at the third position)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wild type GLP-1
Number of subjects: 0
Study: 33453417

Group type: EXPERIMENTAL
Intervention: Real-time moderate-to-high-intensity exercise training (2 to 3 sessions per week for 3 months)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Real-time moderate-to-high-intensity exercise training
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 32
Study: 32865282

Group type: EXPERIMENTAL
Intervention: In vitro fertilisation group (n = 198)
Number of subjects: 1619

Group type: COMPARATOR
Intervention: Control group (n = 1421)
Number of subjects: 1619

Group type: EXPERIMENTAL
Intervention: Gonadotropin-stimulated in vitro fertilisation
Number of subjects: 1619
Study: 35662546

Group type: EXPERIMENTAL
Intervention: CO2 vaginal laser treatment
Number of subjects: 101
Study: 34561665

Group type: EXPERIMENTAL
Intervention: Removable partial denture (RPD)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Shortened dental arch (SDA)
Number of subjects: 215
Study: 32036258

Group type: COMPARATOR
Intervention: Intrathecal ropivacaine alone (Group C)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intrathecal ropivacaine + 5 μg dexmedetomidine (Group D)
Number of subjects: 60
Study: 34397402

Group type: EXPERIMENTAL
Intervention: Platelet rich plasma (PRP) injection
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline injection (Control)
Number of subjects: 60
Study: 32961126

Group type: EXPERIMENTAL
Intervention: Nasal airway used just before nasotracheal intubation (NTI) during mask ventilation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no nasal airway used)
Number of subjects: 70
Study: 36123418

Group type: EXPERIMENTAL
Intervention: Prolonged mechanical ventilation (MV)
Number of subjects: 4809

Group type: EXPERIMENTAL
Intervention: Shorter durations of mechanical ventilation (MV)
Number of subjects: 4809
Study: 35279741

Group type: EXPERIMENTAL
Intervention: Combined therapy with apremilast and narrowband UVB
Number of subjects: 0

Group type: COMPARATOR
Intervention: Narrowband UVB monotherapy
Number of subjects: 0
Study: 35677371

Group type: EXPERIMENTAL
Intervention: Orthodontics plus implant anchorage
Number of subjects: 90

Group type: COMPARATOR
Intervention: Orthodontics alone
Number of subjects: 90
Study: 32306091

Group type: EXPERIMENTAL
Intervention: Older patients (≥75 years) undergoing primary UKA
Number of subjects: 282
Study: 35243631

Group type: EXPERIMENTAL
Intervention: $2 bill incentive
Number of subjects: 1267

Group type: COMPARATOR
Intervention: Control group with no incentive
Number of subjects: 1267

Group type: EXPERIMENTAL
Intervention: Non-monetary incentive (customized pen/stylus)
Number of subjects: 1267

Group type: EXPERIMENTAL
Intervention: First-class stamps
Number of subjects: 1267

Group type: EXPERIMENTAL
Intervention: Bulk mail
Number of subjects: 1267
Study: 34571463

Group type: EXPERIMENTAL
Intervention: Severe weight loss (grade 2-3)
Number of subjects: 524

Group type: COMPARATOR
Intervention: Non-severe weight loss
Number of subjects: 524
Study: 36273083

Group type: EXPERIMENTAL
Intervention: Oral vitamin D3 (cholecalciferol) supplementation, weekly for six weeks
Number of subjects: 22
Study: 32431062

Group type: EXPERIMENTAL
Intervention: p53 Immunohistochemistry (IHC)
Number of subjects: 970
Study: 34521277

Group type: EXPERIMENTAL
Intervention: Isatuximab plus pomalidomide and dexamethasone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pomalidomide and dexamethasone (control)
Number of subjects: 0
Study: 34424533

Group type: EXPERIMENTAL
Intervention: Moisturisers from the first 2 weeks of life
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group without moisturisers
Number of subjects: 200
Study: 33220115

Group type: EXPERIMENTAL
Intervention: Training stop‐smoking practitioners to deliver support according to the NCSCT Standard Treatment Programme
Number of subjects: 502

Group type: COMPARATOR
Intervention: Usual care (brief support and follow‐up)
Number of subjects: 502
Study: 32703092

Group type: EXPERIMENTAL
Intervention: Online, synchronous video counseling
Number of subjects: 49

Group type: COMPARATOR
Intervention: In-person counseling
Number of subjects: 49
Study: 34178837

Group type: EXPERIMENTAL
Intervention: Capsaicin 8% patch
Number of subjects: 291

Group type: COMPARATOR
Intervention: 5% Lidocaine patch
Number of subjects: 291
Study: 34620774

Group type: EXPERIMENTAL
Intervention: Social media-based community consultation (CC) using Facebook and Instagram advertisements
Number of subjects: 332081
Study: 32669234

Group type: EXPERIMENTAL
Intervention: Recreational digital media activities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Personal care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise activities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daily digital media activity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Travel time
Number of subjects: 0
Study: 35060967

Group type: EXPERIMENTAL
Intervention: Open-flap (OF) technique using Er,Cr:YSGG laser
Number of subjects: 36

Group type: COMPARATOR
Intervention: Flapless (FL) technique using Er,Cr:YSGG laser
Number of subjects: 36
Study: 33886115

Group type: EXPERIMENTAL
Intervention: Dydrogesterone and doxycycline
Number of subjects: 188

Group type: COMPARATOR
Intervention: Single antibiotic
Number of subjects: 188
Study: 32841892

Group type: EXPERIMENTAL
Intervention: Low-intensity interventions for individuals with low interpersonal risks and concurrent protective psychological factors
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: High-intensity interventions for individuals with high interpersonal risks and clinical symptoms
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Classes 1 and 2
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Class 1
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Class 3
Number of subjects: 227
Study: 34762756

Group type: EXPERIMENTAL
Intervention: Talking with Voices (novel intervention for supporting distressed voice-hearers)
Number of subjects: 5
Study: 35770602

Group type: EXPERIMENTAL
Intervention: Joint Mobilization
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 45
Study: 32782170

Group type: EXPERIMENTAL
Intervention: GnRH agonist (GnRHa) for 3 months before IVF
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo for 3 months before IVF
Number of subjects: 200
Study: 32594783

Group type: EXPERIMENTAL
Intervention: Lowered seat height by 5.08 cm below lower-leg length
Number of subjects: 50

Group type: COMPARATOR
Intervention: Higher seat heights
Number of subjects: 50
Study: 33687783

Group type: EXPERIMENTAL
Intervention: Ultra rapid lispro (URLi)
Number of subjects: 432
Study: 33107418

Group type: COMPARATOR
Intervention: Δ9‐THC (1.19 mg/2 ml)
Number of subjects: 16
Study: 36502500

Group type: EXPERIMENTAL
Intervention: Topical 1% hexylresorcinol
Number of subjects: 32

Group type: COMPARATOR
Intervention: Topical 2% hydroquinone
Number of subjects: 32
Study: 34418415

Group type: EXPERIMENTAL
Intervention: Lung ultrasound-guided treatment strategy
Number of subjects: 367

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 367
Study: 32962735

Group type: EXPERIMENTAL
Intervention: Mannose supplementation at a total of 1-2 g mannose/kg b.w./d divided into 5 single doses
Number of subjects: 20
Study: 36079841

Group type: EXPERIMENTAL
Intervention: MED‐02 (5 × 10^9 CFU/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 34083403

Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg daily for 3 days followed by 250 mg daily for 12 days + Hydroxychloroquine 200 mg twice daily for 15 days
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Azithromycin + Hydroxychloroquine
Number of subjects: 117
Study: 32495498

Group type: EXPERIMENTAL
Intervention: Baby Friendly Community Initiative (BFCI) intervention
Number of subjects: 270

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 270
Study: 36052304

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (2000 IU/day)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 33635829

Group type: EXPERIMENTAL
Intervention: Women with PCOS
Number of subjects: 21292

Group type: COMPARATOR
Intervention: Women without PCOS (control)
Number of subjects: 21292
Study: 32638409

Group type: EXPERIMENTAL
Intervention: High protein-low carbohydrate (HP-LC) meal
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: High protein-low fat (HP-LF) meal
Number of subjects: 17

Group type: COMPARATOR
Intervention: STANDARD meal (55% carbohydrate, 30% fat, 15% protein)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Food consumption (general intervention)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Fasting proinsulin to insulin ratio
Number of subjects: 17
Study: 35352698

Group type: EXPERIMENTAL
Intervention: Papilloguard (Noyan Pajouhan Biopharma)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Cervarix (GlaxoSmithKline)
Number of subjects: 218
Study: 33783846

Group type: EXPERIMENTAL
Intervention: Combination of hypnosis and TENS
Number of subjects: 72

Group type: COMPARATOR
Intervention: TENS alone
Number of subjects: 72
Study: 32844813

Group type: EXPERIMENTAL
Intervention: Immediate implants (Type 1 ITI protocol)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Delayed implants (Type 4 ITI protocol)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 13
Study: 35084323

Group type: EXPERIMENTAL
Intervention: tofacitinib
Number of subjects: 47
Study: 34421796

Group type: EXPERIMENTAL
Intervention: Intravenous administration of GTN (5 mg GTN in 50 ml saline at a rate of 0.4 mg/h for 12.5 h/day for 2 days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intravenous administration of 0.9% normal saline (NS) (total 50 ml/day at 4 ml/h for 12.5 h/day for 2 days)
Number of subjects: 40
Study: 34027846

Group type: EXPERIMENTAL
Intervention: Recommended dairy (RDa; 4 servings/d)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Low dairy (LDa; ≤ 2 servings/d)
Number of subjects: 46
Study: 33256841

Group type: EXPERIMENTAL
Intervention: Ankylosing spondylitis (AS) cohort
Number of subjects: 6440

Group type: EXPERIMENTAL
Intervention: Ankylosing spondylitis (AS) cohort aged below 49 years
Number of subjects: 6440

Group type: EXPERIMENTAL
Intervention: Ankylosing spondylitis (AS) cohort aged above 65 years
Number of subjects: 6440

Group type: EXPERIMENTAL
Intervention: Ankylosing spondylitis (AS) cohort with comorbidities
Number of subjects: 6440

Group type: EXPERIMENTAL
Intervention: Ankylosing spondylitis (AS) cohort without comorbidities
Number of subjects: 6440

Group type: EXPERIMENTAL
Intervention: NSAID use in AS cohort
Number of subjects: 6440

Group type: EXPERIMENTAL
Intervention: Immunosuppressants in AS cohort
Number of subjects: 6440
Study: 33108905

Group type: EXPERIMENTAL
Intervention: CFP stem
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Corail stem
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study: 33879585

Group type: EXPERIMENTAL
Intervention: Convalescent plasma
Number of subjects: 126
Study: 32380135

Group type: EXPERIMENTAL
Intervention: Electric tooth-brushing with NaF (group 2)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Electric tooth-brushing with SnF2 (group 3)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Dab-on application of NaF (group 4)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Dab-on application of SnF2 (group 5)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Artificial saliva control (group 1)
Number of subjects: 75
Study: 33915006

Group type: EXPERIMENTAL
Intervention: Remdesivir (RDV)
Number of subjects: 57
Study: 32650077

Group type: EXPERIMENTAL
Intervention: Deltopectoral approach (DP)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Deltoid split approach (DS)
Number of subjects: 85
Study: 35113322

Group type: EXPERIMENTAL
Intervention: LCS video decision aid including information on incidental findings
Number of subjects: 348

Group type: COMPARATOR
Intervention: Control video decision aid
Number of subjects: 348
Study: 32181569

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 928

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 928

Group type: EXPERIMENTAL
Intervention: Glycoprotein IIb/IIIa inhibitors (GPI)
Number of subjects: 928
Study: 36350567

Group type: EXPERIMENTAL
Intervention: Localization of MedlinePlus resources customized with community components
Number of subjects: 134

Group type: COMPARATOR
Intervention: No localized community components (Control)
Number of subjects: 134
Study: 34402665

Group type: EXPERIMENTAL
Intervention: Full prediction model based on clinical characteristics and MRI findings
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: Prediction model based solely on readily available MRI findings and age
Number of subjects: 454
Study: 32330548

Group type: EXPERIMENTAL
Intervention: PE + MI
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: PE + MI + RA
Number of subjects: 692
Study: 35684140

Group type: EXPERIMENTAL
Intervention: High-dose eggshell membrane
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose eggshell membrane
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 0
Study: 34952518

Group type: EXPERIMENTAL
Intervention: Interspinous process distraction devices (IPD) implantation
Number of subjects: 159

Group type: COMPARATOR
Intervention: Spinal bony decompression
Number of subjects: 159
Study: 32736299

Group type: EXPERIMENTAL
Intervention: Beverage supplemented with ora-pro-nobis (OPN) flour
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (same beverage without OPN)
Number of subjects: 24
Study: 34047177

Group type: EXPERIMENTAL
Intervention: 6TG added to MTX/6MP maintenance therapy
Number of subjects: 30
Study: 35659172

Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab (NIVO + IPI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Platinum-doublet chemotherapy (PDC)
Number of subjects: 0
Study: 34138468

Group type: EXPERIMENTAL
Intervention: IVIG (25 g/day for three days)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 32865577

Group type: EXPERIMENTAL
Intervention: Tele-BA (behavioral activation) treatment delivered by lay counselors
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Tele-PST (problem-solving therapy) delivered by licensed clinicians
Number of subjects: 277

Group type: COMPARATOR
Intervention: Attention Control (AC; telephone support calls)
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Tele-BA vs Tele-PST
Number of subjects: 277
Study: 34602412

Group type: EXPERIMENTAL
Intervention: Capsule Picolin (500 mg, two capsules thrice a day)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Tablet Picolin-E (250 mg, thrice a day)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Metformin (500 mg, twice a day)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Capsule Picolin
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Tablet Picolin-E
Number of subjects: 73

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 73
Study: 32603238

Group type: EXPERIMENTAL
Intervention: Sports Stars intervention (8 weeks, 8 hours of physiotherapist-led training)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Sports Stars intervention
Number of subjects: 54

Group type: COMPARATOR
Intervention: Waitlist-control group
Number of subjects: 54
Study: 32447973

Group type: EXPERIMENTAL
Intervention: MDS 3.0 assessment of depression PHQ-9
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: MDS 3.0 assessment of behavioral symptoms
Number of subjects: 446
Study: 35439983

Group type: EXPERIMENTAL
Intervention: Nomogram incorporating independent prognostic factors (age, AJCC 8th edition T, N and M stage, carcinoembryonic antigen (CEA), tumour differentiation, chemotherapy, perineural invasion, LNR)
Number of subjects: 8470

Group type: EXPERIMENTAL
Intervention: Nomogram
Number of subjects: 8470
Study: 32930057

Group type: EXPERIMENTAL
Intervention: Integrated intervention for PTSD and SUD (Seeking Safety)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Relapse prevention training (RPT)
Number of subjects: 226
Study: 32102310

Group type: EXPERIMENTAL
Intervention: Smartphone-based maternal nutritional education programme
Number of subjects: 110

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 110
Study: 34612583

Group type: COMPARATOR
Intervention: Upper blepharoplasty without orbicularis oculi muscle excision (group A)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Upper blepharoplasty with orbicularis oculi muscle excision (group B)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 54
Study: 35213345

Group type: EXPERIMENTAL
Intervention: Vibration-Plus Stabilization Exercise (VSE)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Conventional Stabilization Exercise (CSE)
Number of subjects: 62
Study: 35415837

Group type: EXPERIMENTAL
Intervention: Operating exoscope
Number of subjects: 28

Group type: COMPARATOR
Intervention: Operating microscope
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Overall evaluation experience
Number of subjects: 28
Study: 33658358

Group type: EXPERIMENTAL
Intervention: Teplizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36307314

Group type: EXPERIMENTAL
Intervention: Qili Qiangxin Capsule combined with cardiac exercise rehabilitation
Number of subjects: 93

Group type: COMPARATOR
Intervention: Routine treatment
Number of subjects: 93
Study: 34443468

Group type: EXPERIMENTAL
Intervention: Oral treatment with hydrolyzed fish cartilage for 90 days
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 34758186

Group type: EXPERIMENTAL
Intervention: Single intraoperative application of ciprofloxacin drops
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Extended 5 day postoperative application of ciprofloxacin drops
Number of subjects: 256

Group type: COMPARATOR
Intervention: No drops (control)
Number of subjects: 256
Study: 33893355

Group type: EXPERIMENTAL
Intervention: Isocaloric high-protein diets
Number of subjects: 31

Group type: COMPARATOR
Intervention: Liver fat indices
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Weight-independent diets
Number of subjects: 31
Study: 35427193

Group type: EXPERIMENTAL
Intervention: Fast Track Friendship Group program (n = 110)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Treatment-as-usual control group (n = 114)
Number of subjects: 224
Study: 34304292

Group type: EXPERIMENTAL
Intervention: Home-based strength exercise (twice weekly for 10 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Wait list control
Number of subjects: 40
Study: 33168045

Group type: EXPERIMENTAL
Intervention: Integrated GTV-TNM stratification system
Number of subjects: 340
Study: 36231353

Group type: EXPERIMENTAL
Intervention: Action Observation combined with Motor Imagery (AO + MI)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Action Observation (AO)
Number of subjects: 45
Study: 33951895

Group type: EXPERIMENTAL
Intervention: Low Vision Quality of Life Questionnaire (LVQOL)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: National Eye Institute Visual Function Questionnaire (NEI VFQ‐25)
Number of subjects: 64
Study: 32770612

Group type: EXPERIMENTAL
Intervention: Usual care plus gabapentin titrated to drug tolerance during radiation
Number of subjects: 79

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 79
Study: 36214928

Group type: EXPERIMENTAL
Intervention: CHPE150
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CHPE300
Number of subjects: 30

Group type: COMPARATOR
Intervention: CON
Number of subjects: 30
Study: 34469765

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination strategy (including at least two blood pressure lowering agents plus a statin, with or without aspirin)
Number of subjects: 18162

Group type: COMPARATOR
Intervention: Control group (placebo or usual care)
Number of subjects: 18162

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination strategy (with aspirin)
Number of subjects: 18162

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination strategy (without aspirin)
Number of subjects: 18162

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination strategy
Number of subjects: 18162

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination strategy with aspirin
Number of subjects: 18162

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18162

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination treatment
Number of subjects: 18162
Study: 32142113

Group type: EXPERIMENTAL
Intervention: Atrial fibrillation ablation on continuous anticoagulation
Number of subjects: 633